| Nov 15 |
All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy
|
| Nov 15 |
Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 13 |
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...
|
| Nov 13 |
Clearside Biomedical, Inc. (CLSD) Q3 2024 Earnings Conference Call Transcript
|
| Nov 12 |
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 12 |
Clearside Biomedical GAAP EPS of -$0.10 beats by $0.02, revenue of $1.03M beats by $0.91M
|
| Nov 12 |
Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 11 |
Clearside Biomedical Q3 2024 Earnings Preview
|
| Nov 10 |
Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years
|
